People on the Move
Depomed
Depomed, a specialty pharmaceutical company that makes products for pain and neurology-related disorders, has appointed a new Chief Medical Officer and Senior VP.
Srinivas Rao was the founder and CEO of Kyalin Biosciences, a private biotech focused on developing an autism therapy until its sale to Retrophin in 2013. Rao also served as Executive VP and Head of Neuroscience at Retrophin, and as Chief Medical Officer of three companies related to Avalon Ventures. Between 2001 and 2011, he was Chief Scientific Officer of Cypress Bioscience, where he developed Savella, a drug for fibromyalgia which was approved by the US FDA in 2009.
Depomed’s products include Gralise (gabapentin) for the management of postherpetic neuralgia, and Cambia (diclofenac potassium), a non-steroidal anti-inflammatory for migraines.